The 47 most sponsor-active Pharmaceuticals newsletters, ranked by our Newsletter Leader Score.
A weekday briefing on biotech and pharmaceutical-industry developments, including clinical readouts, FDA actions, drug pricing, gene therapy, partnerships, and dealmaking.
A pharmaceutical-economics publication covering drug pricing, wholesalers, specialty pharmacies, PBMs, reimbursement, biosimilars, and the U.S. drug-distribution system. Its audience includes pharmaceutical manufacturers, pharmacy executive…
Global biopharmaceutical industry newsletter and media platform covering drug discovery, development, formulation, manufacturing, CDMOs, biologics, diagnostics, and commercialization. Its audience includes senior pharmaceutical, biotech, ma…
A daily biopharma news briefing from Endpoints News covering drug development, clinical trials, FDA policy, financing, licensing, M&A, manufacturing, and pharmaceutical company strategy. The Early Edition is delivered to readers each U.S. m…
Daily pharmaceutical industry newsletter and publication covering drug development, regulatory approvals, commercialization, payer negotiations, manufacturing, patents, pricing, and M&A.
A weekly global pharmaceutical and biopharmaceutical newsletter covering drug development, CDMOs, CROs, regulation, market trends, deals, technology, and industry interviews. It sells banners, sponsored emails, product spotlights, and spons…
An independent monthly publication covering GLP-1 medicines, pharmaceutical compounding, generic-drug supply, peptide manufacturing, testing, regulation, and the research-peptide supply chain. Its email edition includes a monthly issue noti…
A weekly biotech and pharmaceutical science newsletter covering drug discovery, therapeutic innovation, scientific papers, funding rounds, and emerging technology across bio and life sciences.
Weekday life-science briefing covering pharmaceutical pipelines, clinical development, FDA activity, regulatory decisions, financing, deals, and commercial strategy.
A weekly biopharma and healthcare newsletter covering strategic partnerships, drug development, clinical trials, regulatory milestones, medtech, M&A, and industry intelligence for life-sciences professionals.
Paid and free newsletter providing insider analysis of Big Pharma strategy, competitive positioning, M&A, portfolio decisions, and biopharma market signals.
A daily pharmaceutical-industry newsletter covering drug R&D, commercialization, regulatory developments, market strategy, executives, and biopharma business trends.
A weekly business-intelligence newsletter covering AI drug discovery, computational biology, emerging therapeutic modalities, pharma R&D transformation, biotech startups, and life-sciences technology. The publisher reports more than 11,000 …
A weekly leadership newsletter for senior pharmaceutical executives, focused on decision-making, organizational performance, strategic execution, management, and the realities of leading pharma teams.
A weekly newsletter explaining the trials, approvals, deals and science shaping biotech and pharma. It combines industry news with company spotlights, investment context and accessible scientific analysis.
Biopharmaceutical business-news newsletter covering biologics manufacturing, bioprocessing investments, capacity expansion, M&A, regulation, cell and gene therapies, and commercialization. It targets technical, operational, and executive de…
A daily STAT newsletter covering the global pharmaceutical industry, including drug pricing, patents, regulation, litigation, company strategy, and leadership changes. It is written by veteran pharma journalist Ed Silverman.
A daily pharmaceutical manufacturing newsletter focused on drug production, process development, GMP, quality, supply chain, automation, and Pharma 4.0. The publication sells newsletter and broader B2B advertising inventory to pharmaceutica…
The Pharma Letter delivers global pharmaceutical, biotechnology, generics, regulatory, M&A, clinical-development, and commercial news through daily online coverage and email alerts. Its readers include pharmaceutical executives, investors, …
Weekly pharmaceutical-industry newsletter covering drug commercialization, patient access, supply chain, logistics, market access, regulation, and healthcare innovation.
Weekly newsletter focused on clinical development of pharmaceuticals, including clinical research, regulatory developments, trial operations, data disclosure, and medical affairs.
A recurring newsletter covering pharmaceutical and biotech deals, clinical development, regulatory decisions, drug approvals, financing and industry strategy. It is written for pharmaceutical and biotechnology professionals and investors.
A weekly toxicology and nonclinical drug-development newsletter explaining IND-enabling strategy, GLP requirements, study design, species selection, safety margins, and regulatory decision-making. It is aimed at scientists, biotech founders…
A paid and free biotech investing newsletter focused on binary clinical catalysts, Phase 2 and Phase 3 readouts, PDUFA dates, M&A speculation and scientific-commercial interpretation of pharmaceutical companies.
A Monday-through-Saturday life-sciences newsletter featuring pharmaceutical, biotech, drug-discovery, bioprocessing, and translational-medicine news and analysis.
Subscription newsletter analyzing biotech and pharmaceutical stocks, clinical catalysts, product pipelines, valuation, and investment implications.
Weekly, opinionated intelligence newsletter on artificial intelligence adoption in pharmaceutical and biotechnology R&D, commercial operations, scientific workflows, and enterprise strategy.
Newsletter and digital publication focused on biopharmaceutical development and manufacturing, including biologics, ADCs, cell and gene therapies, process development, quality, and technology transfer. Its readership consists primarily of b…
Daily APAC-focused pharmaceutical, biotech, and healthcare newsletter covering drug discovery, clinical trials, regulatory developments, biologics, vaccines, cell and gene therapy, manufacturing, investment, and partnerships. It serves phar…
Biweekly global life-sciences newsletter covering pharmaceutical and biotech innovation, investment, CROs, AI, commercial strategy, partnerships, and market development.
A weekly pharmaceutical-industry intelligence newsletter covering drug delivery, formulation, pharmaceutical development, biologics, diagnostics, manufacturing, regulatory trends, and industry strategy.
A global weekly life-sciences newsletter featuring executive interviews, pharmaceutical-market intelligence, policy, market access, innovation, and regional industry analysis. PharmaBoardroom reports an email database of approximately 26,00…
Weekly newsletter for pharmaceutical and biopharmaceutical outsourcing professionals, covering CDMOs, contract manufacturing, external development, supply chains, regulatory issues, and industry events.
An independent biotech and pharmaceutical investment newsletter focused on small- and mid-cap companies, clinical catalysts, mechanisms, regulatory paths and commercial opportunity. Coverage includes both emerging biotechs and larger pharma…
A biopharma investment and strategy newsletter examining biotechnology valuation, capital markets, clinical readouts, company rebuilding and the relationship between science, patients, operators and investors.
An independent weekly bulletin covering the British biotech and pharmaceutical ecosystem, including company funding, licensing, M&A, drug-development science, talent, accelerators, and Big Pharma activity.
Pharmaceutical Technology's Daily Newsletter covers drug development, FDA and global regulatory decisions, clinical trials, manufacturing, commercialization, and pharmaceutical business strategy. It is aimed at pharmaceutical executives, re…
Digital Compliance is a specialist newsletter about pharmaceutical quality systems, GxP, computer-system validation, AI governance, Annex 11, and digital transformation. It is written for QA, validation, compliance, IT, and digital-transfor…
The Medication Monitor is a monthly pharmaceutical newsletter covering FDA and EMA approvals, drug safety, recalls, regulatory guidance, and selected oncology and rare-disease developments. It is aimed at pharmacovigilance, regulatory-affai…
Daily briefing covering biotech, pharmaceuticals, clinical trials, FDA activity, drug approvals, financing, M&A, and market-moving developments. The newsletter is designed for rapid reading by professionals across the life-sciences ecosyste…
Drug Discovery News's Discovery Insider is an industry newsletter covering drug discovery, development, manufacturing, analytical technologies, and life-science research. It targets scientists, pharmaceutical R&D teams, biotech companies, a…
A recurring pharmaceutical engineering newsletter covering manufacturing, quality, regulatory affairs, facilities, supply chain, automation, and Pharma 4.0. ISPE sells banner, text-ad, weekly-package, and monthly-package placements.
A weekday pharmaceutical, medical-device, laboratory, and biopharma news digest curated for professionals inside the life-sciences industry.
Daily biotech and pharmaceutical policy newsletter covering drug-development policy, regulation, public affairs, industry economics, and biotechnology innovation.
A high-frequency biotech and pharmaceutical newsletter covering public and private markets, drug-development strategy, clinical data, financing, regulatory decisions, company building, and emerging therapeutic science. The publication descr…
Pulse is a recurring pharmaceutical-industry briefing focused on FDA announcements, drug approvals, regulatory developments, and other pharmaceutical news. It is produced for professionals who need a concise regulatory and market update.
High-density pharmaceutical news briefing synthesizing regulatory approvals, clinical developments, M&A, financing, drug-discovery technology, and major global pharma-company activity.
These are real sponsors backing the communities on this list — discovered by Sponsor Scout's daily AI agent. Sign up free to see who's actively sponsoring right now, find the decision-makers, and reach out.
Property owners can submit evidence for Sponsor Scout review. Acceptance into Sponsor Scout does not guarantee placement in the public Top 25; rankings remain evidence-based and editorially independent.
Sign up to submit → Already have an account? Sign inEvery newsletter is scored 0–100 by Sponsor Scout as we search the open web daily. The score rewards newsletters that reach real audiences and consistently attract sponsors. These findings are updated regularly.
Sponsor Scout hunts the web every day for companies sponsoring startup & tech events, finds the right decision-maker, and drafts the outreach for you. Start free — 20 sponsors and 4 scout runs every month, no credit card.
One short email each weekday: a real story about a real company sponsoring the startup ecosystem, plus the day's freshest finds.